Support

Matthew A. Coleman, Ph.D., is Associate Adjunct Professor at the University of California, Davis (UC-Davis) in the Department of Radiation Oncology and a member of the NIH Cancer Center. He is also an appointed Senior Staff Scientist at LLNL. Prior to his professorship at UC-Davis, he obtained a B.S., in Biology from the University of Massachusetts (1987), and a Ph.D., in Biophysics from Boston University (1997). Additionally, in 1997, he embarked in a Genomic Studies program at LLNL.

In addition, to his academic advisory role at UC-Davis, Dr. Coleman's current activities include steering various UC-Davis programs, including UC-Davis' Industry-University Cooperative Research Program. He has authored over 60 publications in peer-reviewed journals, published proceedings and book chapters covering a diverse breadth of molecular biology and biochemistry. Dr. Coleman has three patents and six patents pending related to biomarker discovery and biotechnology. For his work in the area of nanolipoproteins -membrane protein complexes, Dr. Coleman received a Nanotechnology 50 award for co-development of his innovative approach to produce and solubilize membrane proteins using nanoparticles.

Dr. Coleman's research focuses on understanding the processes involved in genome instability following genotoxic stresses such as ionizing radiation. His research also uses novel approaches in nanotechnology, using nanolipoproteins to help characterize biological components involved in cell signaling.